DK1881967T3 - Substituerede benzo (D) isoaxol-3-yl-amin-forbindelser som analgetika - Google Patents

Substituerede benzo (D) isoaxol-3-yl-amin-forbindelser som analgetika

Info

Publication number: DK1881967T3
Authority: DK; Denmark
Prior art keywords: isoaxol; analgesics; amine compounds; substituted benzo; compounds
Prior art date: 2005-05-18

Application number

DK06753695.3T

Other languages

English (en)

Inventor

Beatrix Merla

Robert Frank

Gregor Bahrenberg

Wolfgang Schroeder

Saskia Zemolka

Original Assignee

Gruenenthal Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-05-18

Filing date

2006-05-18

Publication date

2010-08-16

2006-05-18 Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh

2010-08-16 Application granted granted Critical

2010-08-16 Publication of DK1881967T3 publication Critical patent/DK1881967T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Addiction (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Pulmonology (AREA)
Urology & Nephrology (AREA)
Diabetes (AREA)
Cardiology (AREA)
Hematology (AREA)
Psychology (AREA)
Dermatology (AREA)
Obesity (AREA)
Heart & Thoracic Surgery (AREA)
Rheumatology (AREA)
Hospice & Palliative Care (AREA)
Child & Adolescent Psychology (AREA)
Ophthalmology & Optometry (AREA)
Anesthesiology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Plural Heterocyclic Compounds (AREA)
Compositions Of Macromolecular Compounds (AREA)

DK06753695.3T 2005-05-18 2006-05-18 Substituerede benzo (D) isoaxol-3-yl-amin-forbindelser som analgetika DK1881967T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE102005023589		2005-05-18
DE102005038947A DE102005038947A1 (de)	2005-05-18	2005-08-16	Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln
PCT/EP2006/004700 WO2006122800A1 (de)	2005-05-18	2006-05-18	Substituierte benzo (d) isoaxol-3-yl-amin-verbindungen als analgetika

Publications (1)

Publication Number	Publication Date
DK1881967T3 true DK1881967T3 (da)	2010-08-16

Family

ID=36699120

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK06753695.3T DK1881967T3 (da)	2005-05-18	2006-05-18	Substituerede benzo (D) isoaxol-3-yl-amin-forbindelser som analgetika
DK06742972T DK1888541T3 (da)	2005-05-18	2006-05-18	Benzo(d)isoxazol-3-yl-amin-forbindelser og anvendelse af disse som vanilloidreceptorligander

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DK06742972T DK1888541T3 (da)	2005-05-18	2006-05-18	Benzo(d)isoxazol-3-yl-amin-forbindelser og anvendelse af disse som vanilloidreceptorligander

Country Status (15)

Country	Link
US (2)	US7977360B2 (da)
EP (2)	EP1881967B1 (da)
JP (2)	JP2008540597A (da)
AT (2)	ATE466002T1 (da)
AU (1)	AU2006249065B2 (da)
CA (2)	CA2608386A1 (da)
CY (2)	CY1109568T1 (da)
DE (3)	DE102005038947A1 (da)
DK (2)	DK1881967T3 (da)
ES (2)	ES2344272T3 (da)
PL (2)	PL1881967T3 (da)
PT (2)	PT1888541E (da)
RU (1)	RU2416607C2 (da)
SI (2)	SI1881967T1 (da)
WO (2)	WO2006122800A1 (da)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8933236B2 (en)	2012-05-22	2015-01-13	Xenon Pharmaceuticals Inc.	N-substituted benzamides and methods of use thereof
DE102005038947A1 (de) *	2005-05-18	2006-11-30	Grünenthal GmbH	Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln
US20100080773A1 (en)	2008-09-26	2010-04-01	Sdg, Inc.	Orally Bioavailable Lipid-Based Constructs
CN101925575B (zh)	2008-01-28	2014-06-18	株式会社爱茉莉太平洋	作为香草酸受体拮抗剂的化合物、其异构体或其药物学可接受的盐、及包含这些化合物的药物组合物
WO2010002209A2 (en)	2008-07-02	2010-01-07	Amorepacific Corporation	Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist and pharmaceutical compositions containing the same
US8349852B2 (en)	2009-01-13	2013-01-08	Novartis Ag	Quinazolinone derivatives useful as vanilloid antagonists
TWI504395B (zh)	2009-03-10	2015-10-21		Substituted 3-amino-2-mercaptoquinoline as a KCNQ2 / 3 modifier
WO2010102778A2 (de) *	2009-03-10	2010-09-16	Grünenthal GmbH	Substituierte 3-aminoisoxazolopyridine als kcnq2/3 modulatoren
TW201038565A (en)	2009-03-12	2010-11-01	Gruenenthal Gmbh	Substituted 2-mercapto-3-aminopyridines as KCNQ2/3 modulators
TWI461197B (zh)	2009-03-12	2014-11-21		2-mercaptoquinoline-3-carboxamide as a KCNQ2 / 3 modifier
CN102762572A (zh)	2010-02-01	2012-10-31	诺瓦提斯公司	作为CRF-1受体拮抗剂的吡唑并[5,1b]*唑衍生物
WO2011092293A2 (en)	2010-02-01	2011-08-04	Novartis Ag	Cyclohexyl amide derivatives as crf receptor antagonists
CN102753527B (zh)	2010-02-02	2014-12-24	诺华股份有限公司	用作crf受体拮抗剂的环己基酰胺衍生物
AU2011215645A1 (en)	2010-02-11	2012-09-20	Vanderbilt University	Benzisoxazoles and azabenzisoxazoles as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
AR082733A1 (es)	2010-08-27	2012-12-26	Gruenenthal Gmbh	2-amino-quinolina-3-carboxamidas sustituidas como moduladores de kcnq2/3
PE20140214A1 (es)	2010-08-27	2014-02-19	Gruenenthal Chemie	2-oxo- y 2-tioxo-dihidroquinolina-3-carboxamidas sustituidos como moduladores kcnq2/3
BR112013004562A2 (pt)	2010-08-27	2016-09-06	Gruenenthal Gmbh	2-óxi-quinolina-3-carboxamidas substituídas como moduladores kcnq2/3
AU2011297937B2 (en)	2010-09-01	2015-10-01	Grunenthal Gmbh	Substituted 1-oxo-dihydroisoquinoline-3-carboxamides as KCNQ2/3 modulators
WO2013064984A1 (en)	2011-10-31	2013-05-10	Xenon Pharmaceuticals Inc.	Biaryl ether sulfonamides and their use as therapeutic agents
JP6014154B2 (ja)	2011-10-31	2016-10-25	ゼノン・ファーマシューティカルズ・インコーポレイテッドＸｅｎｏｎＰｈａｒｍａｃｅｕｔｉｃａｌｓＩｎｃ．	ベンゼンスルホンアミド化合物および治療剤としてのそれらの使用
BR112015000187A2 (pt)	2012-07-06	2017-06-27	Genentech Inc	benzamidas substituídas com n e métodos de uso das mesmas
KR20150131233A (ko)	2013-03-14	2015-11-24	제넨테크, 인크.	치환된 트리아졸로피리딘 및 이의 사용 방법
US9493429B2 (en)	2013-03-15	2016-11-15	Genentech, Inc.	Substituted benzoxazoles and methods of use thereof
CR20160296A (es)	2013-11-27	2016-09-20	Genentech Inc	Benzamidas sustituidas y métodos para usarlas
HK1223358A1 (zh) *	2013-12-20	2017-07-28	吉利德科学公司	作為離子通道調節劑的稠合雜環化合物
WO2016007534A1 (en)	2014-07-07	2016-01-14	Genentech, Inc.	Therapeutic compounds and methods of use thereof
AU2015302908B2 (en)	2014-08-13	2020-02-13	Auckland Uniservices Limited	Inhibitors of tryptophan dioxygenases (IDO1 and TDO) and their use in therapy
US10183938B2 (en)	2014-12-16	2019-01-22	Axovant Sciences Gmbh	Geminal substituted quinuclidine amide compounds as agonists of α-7 nicotonic acetylcholine receptors
WO2016096709A1 (en) *	2014-12-16	2016-06-23	Eudendron S.R.L.	Heterocyclic derivatives modulating activity of certain protein kinases
EP3297989A1 (en)	2015-05-22	2018-03-28	Genentech, Inc.	Substituted benzamides and methods of use thereof
JP2018516973A (ja)	2015-06-10	2018-06-28	フォーラム・ファーマシューティカルズ・インコーポレイテッドＦｏｒｕｍＰｈａｒｍａｃｅｕｔｉｃａｌｓＩｎｃ．	α７−ニコチン性アセチルコリン受容体のアゴニストとしてのアミノベンゾイソオキサゾール化合物
EP3334740A4 (en) *	2015-08-12	2019-02-06	Axovant Sciences GmbH	GEMINAL SUBSTITUTED AMINOBENZISOXAZOLE COMPOUNDS AS AGONISTS OF ALPHA 7-NICOTINIC ACETYLCHOLINE RECEPTORS
CN108137477A (zh)	2015-08-27	2018-06-08	基因泰克公司	治疗化合物及其使用方法
AU2016312848A1 (en)	2015-08-27	2018-03-29	Auckland Uniservices Limited	Inhibitors of tryptophan dioxygenases (IDO1 and TDO) and their use in therapy
CN108290881B (zh)	2015-09-28	2021-12-07	健泰科生物技术公司	治疗性化合物和其使用方法
EP3380466A1 (en)	2015-11-25	2018-10-03	Genentech, Inc.	Substituted benzamides useful as sodium channel blockers
US10766858B2 (en)	2016-03-30	2020-09-08	Genentech, Inc.	Substituted benzamides and methods of use thereof
MX388175B (es)	2016-10-17	2025-03-19	Genentech Inc	Compuestos terapéuticos y métodos para utilizarlos
EP3601273B1 (en)	2017-03-24	2021-12-01	Genentech, Inc.	4-piperidin-n-(pyrimidin-4-yl)chroman-7-sulfonamide derivatives as sodium channel inhibitors
CN112041313A (zh)	2018-02-26	2020-12-04	基因泰克公司	吡啶-磺酰胺化合物及其针对疼痛和相关疾患的用途
JP2021519788A (ja)	2018-03-30	2021-08-12	エフ．ホフマン−ラロシュアーゲーＦ．Ｈｏｆｆｍａｎｎ−ＬａＲｏｃｈｅＡｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ	ナトリウムチャネル阻害剤としての縮合環ヒドロピリド化合物
TW202003490A (zh)	2018-05-22	2020-01-16	瑞士商赫孚孟拉羅股份公司	治療性化合物及其使用方法
GB201810092D0 (en)	2018-06-20	2018-08-08	Ctxt Pty Ltd	Compounds
GB201810581D0 (en)	2018-06-28	2018-08-15	Ctxt Pty Ltd	Compounds
IL288802B2 (en)	2019-06-18	2025-08-01	Pfizer	Benzisoxazole sulfonamide derivatives
JP7788377B2 (ja)	2019-12-04	2025-12-18	シンジェンタクロッププロテクションアクチェンゲゼルシャフト	殺有害生物的に活性な縮合二環式芳香族複素環式アミノ化合物
TW202136239A (zh) *	2019-12-31	2021-10-01	美商ＩｆｍＤｕｅ有限公司	用於治療與ｓｔｉｎｇ活性相關之病狀的化合物及組合物
JP2023513047A (ja)	2020-01-30	2023-03-30	シンジェンタクロッププロテクションアクチェンゲゼルシャフト	殺有害生物的に有効な縮合二環式芳香族複素環式アミノ化合物
CN112142683B (zh) *	2020-09-01	2022-05-24	成都大学	一种氮杂十一元环化合物及其制备方法、用途以及包含该化合物的药物

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE126512T1 (de) *	1989-05-19	1995-09-15	Hoechst Roussel Pharma	N-(aryloxyalkyl)heteroarylpiperidine und - heteroarylpiperazine, verfahren zu ihrer herstellung und ihre verwendung als medikamente.
FI934223L (fi) *	1991-03-28	1993-09-27	Pfizer	Heterocykliscykliska aminderivat
US5328920A (en) *	1991-04-17	1994-07-12	Hoechst-Roussel Pharmaceuticals Incorporated	Substituted (pyridinylamino)-indoles
ES2187518T3 (es) *	1992-11-23	2003-06-16	Aventis Pharma Inc	3-(aminoalquilamino)-1-2-benzisoxazoles sustituidos y compuestos relacionados.
US5494908A (en) *	1992-11-23	1996-02-27	Hoechst-Roussel Pharmaceutical Incorporated	Substituted 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds
ES2157442T3 (es) *	1995-06-06	2001-08-16	Aventis Pharma Inc	Derivados de benzoisoxazol y de indazol, utilizados como agentes neurolepticos.
EP1119570B1 (en) *	1998-10-06	2004-06-16	Janssen Pharmaceutica N.V.	Tricyclic delta3-piperidines as pharmaceuticals
WO2000027627A1 (en) *	1998-11-12	2000-05-18	Eli Lilly And Company	Aryloxime linkers in the solid-phase synthesis of 3-aminobenzisoxazoles
WO2000027199A1 (en) *	1998-11-12	2000-05-18	Eli Lilly And Company	Aminobenzisoxazole compounds and libraries thereof
ATE268766T1 (de) *	1999-07-16	2004-06-15	Bristol Myers Squibb Pharma Co	Stickstoff enthaltende heterobicyclen als factor xa inhibitoren
WO2001087845A2 (en) *	2000-05-15	2001-11-22	Fujisawa Pharmaceutical Co., Ltd.	N-containing heterocyclic compounds and their use as 5-ht antagonists
HUP0303841A2 (hu) *	2001-02-20	2004-03-01	Bristol-Myers Squibb Company	2,4-Diszubsztituált-5-pirimidinkarboxamid-származékok mint KCNQ káliumcsatorna modulátorok és ezeket tartalmazó gyógyszerkészítmények és előállításuk
US6469042B1 (en) *	2001-02-20	2002-10-22	Bristol-Myers Squibb Company	Fluoro oxindole derivatives as modulators if KCNQ potassium channels
MXPA03007397A (es)	2001-02-20	2003-12-04	Bristol Myers Squibb Co	Moduladores de canales de potasio kcnq y uso de los mismos en tratamiento de migrana y enfermedades mecanicamente relacionadas.
US6593349B2 (en) *	2001-03-19	2003-07-15	Icagen, Inc.	Bisarylamines as potassium channel openers
KR100789567B1 (ko) *	2001-11-06	2007-12-28	동화약품공업주식회사	3-아미도-1,2-벤조이소옥사졸 유도체, 그 염, 제조방법 및 용도
DE10229070A1 (de) *	2002-06-28	2004-01-15	Merck Patent Gmbh	Phenylderivate 5
GB0217757D0 (en) *	2002-07-31	2002-09-11	Glaxo Group Ltd	Novel compounds
JO2696B1 (en) *	2002-12-23	2013-03-03	شركة جانسين فارماسوتيكا ان. في	Derivatives of 1-piperdine-4-yl-4-biprolidine-3-yl-piperazine substituted and used as quinine antagonists
PL1638941T3 (pl) *	2003-05-22	2010-11-30	Abbvie Bahamas Ltd	Indazolowe, benzizoksazolowe i benzizotiazolowe inhibitory kinaz
GB0319150D0 (en)	2003-08-14	2003-09-17	Glaxo Group Ltd	Novel compounds
EP1746991A2 (en) *	2004-03-16	2007-01-31	Janssen Pharmaceutica N.V.	Daao inhibiting benzisoxazoles for treating mental disorders
US7759337B2 (en) *	2005-03-03	2010-07-20	Amgen Inc.	Phthalazine compounds and methods of use
DE102005038947A1 (de) *	2005-05-18	2006-11-30	Grünenthal GmbH	Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln
DE102005026194A1 (de) *	2005-06-06	2006-12-07	Grünenthal GmbH	Substituierte N-Benzo[d]isoxazol-3-yl-amin-Derivate und deren Verwendung zur Herstellung von Arzneimitteln
US7989461B2 (en) *	2005-12-23	2011-08-02	Amgen Inc.	Substituted quinazolinamine compounds for the treatment of cancer

2005
- 2005-08-16 DE DE102005038947A patent/DE102005038947A1/de not_active Withdrawn
2006
- 2006-05-18 US US11/914,636 patent/US7977360B2/en not_active Expired - Fee Related
- 2006-05-18 AT AT06753695T patent/ATE466002T1/de active
- 2006-05-18 CA CA002608386A patent/CA2608386A1/en not_active Abandoned
- 2006-05-18 ES ES06753695T patent/ES2344272T3/es active Active
- 2006-05-18 PL PL06753695T patent/PL1881967T3/pl unknown
- 2006-05-18 AT AT06742972T patent/ATE438633T1/de active
- 2006-05-18 JP JP2008511637A patent/JP2008540597A/ja not_active Ceased
- 2006-05-18 PT PT06742972T patent/PT1888541E/pt unknown
- 2006-05-18 AU AU2006249065A patent/AU2006249065B2/en not_active Ceased
- 2006-05-18 JP JP2008511638A patent/JP2008540598A/ja not_active Ceased
- 2006-05-18 DE DE502006004453T patent/DE502006004453D1/de active Active
- 2006-05-18 CA CA002608773A patent/CA2608773A1/en not_active Abandoned
- 2006-05-18 RU RU2007146385/04A patent/RU2416607C2/ru not_active IP Right Cessation
- 2006-05-18 DE DE502006006854T patent/DE502006006854D1/de active Active
- 2006-05-18 EP EP06753695A patent/EP1881967B1/de not_active Not-in-force
- 2006-05-18 DK DK06753695.3T patent/DK1881967T3/da active
- 2006-05-18 DK DK06742972T patent/DK1888541T3/da active
- 2006-05-18 WO PCT/EP2006/004700 patent/WO2006122800A1/de not_active Ceased
- 2006-05-18 PL PL06742972T patent/PL1888541T3/pl unknown
- 2006-05-18 ES ES06742972T patent/ES2331259T3/es active Active
- 2006-05-18 PT PT06753695T patent/PT1881967E/pt unknown
- 2006-05-18 SI SI200630725T patent/SI1881967T1/sl unknown
- 2006-05-18 WO PCT/EP2006/004698 patent/WO2006122799A1/de not_active Ceased
- 2006-05-18 SI SI200630455T patent/SI1888541T1/sl unknown
- 2006-05-18 EP EP06742972A patent/EP1888541B1/de not_active Not-in-force
2007
- 2007-11-16 US US11/941,331 patent/US7696238B2/en not_active Expired - Fee Related
2009
- 2009-11-05 CY CY20091101144T patent/CY1109568T1/el unknown
2010
- 2010-07-15 CY CY20101100664T patent/CY1110209T1/el unknown

Also Published As

Publication number	Publication date
EP1881967B1 (de)	2010-04-28
US7696238B2 (en)	2010-04-13
SI1888541T1 (sl)	2010-01-29
JP2008540598A (ja)	2008-11-20
CA2608386A1 (en)	2006-11-23
DE502006004453D1 (de)	2009-09-17
ATE466002T1 (de)	2010-05-15
US7977360B2 (en)	2011-07-12
HK1112238A1 (zh)	2008-08-29
US20090042945A1 (en)	2009-02-12
CY1109568T1 (el)	2014-08-13
WO2006122800A1 (de)	2006-11-23
PT1888541E (pt)	2009-11-10
DE502006006854D1 (de)	2010-06-10
ATE438633T1 (de)	2009-08-15
WO2006122799A1 (de)	2006-11-23
AU2006249065A1 (en)	2006-11-23
AU2006249065B2 (en)	2011-04-21
RU2416607C2 (ru)	2011-04-20
PL1881967T3 (pl)	2010-10-29
CY1110209T1 (el)	2015-01-14
RU2007146385A (ru)	2009-10-27
DE102005038947A1 (de)	2006-11-30
DK1888541T3 (da)	2009-12-07
EP1881967A1 (de)	2008-01-30
ES2331259T3 (es)	2009-12-28
ES2344272T3 (es)	2010-08-23
PL1888541T3 (pl)	2010-01-29
JP2008540597A (ja)	2008-11-20
CA2608773A1 (en)	2006-11-23
US20080176915A1 (en)	2008-07-24
EP1888541B1 (de)	2009-08-05
PT1881967E (pt)	2010-06-30
SI1881967T1 (sl)	2010-08-31
EP1888541A1 (de)	2008-02-20

Publication	Publication Date	Title
DK1881967T3 (da)	2010-08-16	Substituerede benzo (D) isoaxol-3-yl-amin-forbindelser som analgetika
MX2009003382A (es)	2009-04-08	Derivados de sulfonamidas sustituidos.
MX2007003108A (es)	2007-05-24	Compuestos imidazo-3-il-amina sustituidos y biciclicos.
NO20090295L (no)	2009-01-20	Substituerte heteroarylderivater
PL1891004T3 (pl)	2010-05-31	Pentafluorosulfanylo-podstawiony związek i jego zastosowanie do wytwarzania środków leczniczych
NO20083153L (no)	2008-09-22	Kjemiske forbindelser
NO20091395L (no)	2009-04-06	Nye tiofenderivater
TNSN08024A1 (en)	2009-07-14	7-substituted aza-indazoles, compositions containing same, production method and use thereof
TW200800968A (en)	2008-01-01	Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs
WO2008046581A3 (de)	2008-06-12	Substituierte tetrahydropyrrolopyrazin-verbindungen als inhibitoren der monoaminwiederaufnahme und deren verwendung in arzeimitteln
MX2011009369A (es)	2011-09-27	2-mercaptoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3.
CY1112495T1 (el)	2015-12-09	Κυτταροτοξικοι παραγοντες που περιλαμβανουν νεα παραγωγα τομαϋμυκινης
MX2009007436A (es)	2009-07-22	Derivados espirociclicos de acido tetronico.
MX2011008825A (es)	2011-09-21	3-aminoisoxazolopiridinas sustituidas como moduladores de kcnq2/3.
UA94603C2 (ru)	2011-05-25	Производные тетрагидронафталина, способ их получения и их применения в качестве ингибиторов воспаления
NO20074047L (no)	2007-08-06	Ny fremgangsmate for fremstilling av substituerte indoler
EA200702589A1 (ru)	2008-06-30	2,6-хинолинильные производные, способы их получения и их применение
MX2011008662A (es)	2011-09-06	2-mercapto-3-aminopiridinas sustituidas como moduladores de kcnq2/3.
MX2011009338A (es)	2011-09-27	3-amino-2-mercaptoquinolinas sustituidas como moduladores de kcnq2/3.
TW200740814A (en)	2007-11-01	Compounds
MX2009004983A (es)	2009-05-22	Pirazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion.
TW200700064A (en)	2007-01-01	Novel compounds
MX2008011576A (es)	2008-09-22	Compuestos de imidazo[2,1-b]tiazol sustituidos y su uso para la produccion de farmacos.
DE602006009789D1 (de)	2009-11-26	Acetylenderivate
PL1888514T3 (pl)	2009-08-31	Sole podstawionych estrów kwasu alofanowego i ich zastosowanie w środkach leczniczych